N. Chevalier

Discipline

Economies et finances (2) Philosophie (1)

Type de document

Articles (7) Mémoires, Thèses et HDR (1)

Co-auteur

C. Widmann

D. Barras

R. Renella

J. Puyal

S. Michel

M. Heulot

N. Gross

G. Dubuis

V. Zoete

P.G. Ziros

A. Zheng

P. WASZYK

A. Volorio

G. Vantomme

E. Trofimenko

M. Torsello

G.P. Sykiotis

M.L. Suvà

I. Stamenkovic

M. Serulla

M.N. Rivera

N. Riggi

P. Provero

F. Ory

M.A. Olayioye

P.G. Nielsen

K. Nardou

A. Nahimana

A. Muhlethaler-Mottet

J. Mora

M Montemurro

O. Michielin

P. Martin

C. Margue

A. Lüthi

I. Letovanec

K. Lapouge

D. Kulms

A. Kulkarni

S. Kreis

T. Keskin

J. M. Joseph

N. Jauquier

S. Iyer

G. Grasso

T. Geiser

C. Fusco

M. Flahaut

O. Dormond

A. Digklia

M.A. Deriu

R. Dempsey

A. Danani

L.C. Dam

G.M. Cote

S. Cornaz-Buros

E. Choy

S. Cherix

I. Chebib

A.M. Carcaboso

M. Calderoni

G. Boulay

K. Balmas Bourloud

A. BAKARIC

Y. Arribat

F. Amati

Date

Source

Serveur académique Lausannois (8)

Mot-clé

Cells (7) ligne (4) Expression (4) Cancer (4) Tumors (4) Cancer (3) Tumors (3) Peptides (3) Neuroblastoma (3) Human beings (3) Inhibition (3) Cell death (3) Ability (3) résistance (3) thérapie (2) spectacle (2) mise sous écran protecteur (2) protéine (2) gène (2) effet (2) cancer (2) Development (2) Treatment (2) Children (2) Methods (2) GTPase-activating protein (2) Apoptosis (2) Genes (2) Vincristine (2) Therapeutics (2)

Documents écrit par N. Chevalier (8) | parle de N. Chevalier (6)

Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.

E. Trofimenko et al. (29 oct. 2021)

LIN28B Underlies the Pathogenesis of a Subclass of Ewing Sarcoma LIN28B Control of EWS-FLI1 Stability.

T. Keskin et al. (31 mars 2020)

CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinoma.

A. Zheng et al. (17 déc. 2019)

The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner.

M. Heulot et al. (27 sept. 2016)

Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.

M. Flahaut et al. (2016)

Assessment of the chemosensitizing activity of TAT-RasGAP317-326 in childhood cancers.

N. Chevalier et al. (2015)

A WXW Motif Is Required for the Anticancer Activity of the TAT-RasGAP317-326 Peptide.

D. Barras et al. (2014)

L'implication des cellules de type cellules souches cancéreuses dans la résistance aux drogues du neuroblastome

N. Chevalier (2011)